The NO/cGMP pathway inhibits transient cAMP signals through the activation of PDE2 in striatal neurons

56Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Abstract

The NO-cGMP signaling plays an important role in the regulation of striatal function although the mechanisms of action of cGMP specifically in medium spiny neurons (MSNs) remain unclear. Using genetically encoded fluorescent biosensors, including a novel Epac-based sensor (EPAC-SH150) with increased sensitivity for cAMP we analyze the cGMP response to NO and whether it affected cAMP/PKA signaling in MSNs. The Cygnet2 sensor for cGMP reported large responses to NO donors in both striatonigral and striatopallidal MSNs, this cGMP signal was controlled partially by PDE2. At the level of cAMP brief forskolin stimulations produced transient cAMP signals which differed between D1 and D2 MSNs. NO inhibited these cAMP transients through cGMP-dependent PDE2 activation, an effect that was translated and magnified downstream of cAMP at the level of PKA. PDE2 thus appears as a critical effector of NO which modulates the post-synaptic response of MSNs to dopaminergic transmission. © 2013 Polito, Klarenbeek, Jalink, Paupardin-Tritsch, VincentandCastro.

Cite

CITATION STYLE

APA

Polito, M., Klarenbeek, J., Jalink, K., Paupardin-Tritsch, D., Vincent, P., & Castro, L. R. V. (2013). The NO/cGMP pathway inhibits transient cAMP signals through the activation of PDE2 in striatal neurons. Frontiers in Cellular Neuroscience, 6(NOV). https://doi.org/10.3389/fncel.2013.00211

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free